How many think that this could be the next Intercept Pharma
Sentiment: Strong Buy
never. ICPT was pretty obscure (how manuy on this board owned it, for example), low float. KERX's Z story is pretty much out there, and its good, but there is low probability for surprises.
We have already gone up 400% this year. if we double again I will be thrilled. Treatment of fatty liver and prevention of cirrhosis is huge.
A double would be nice